.svg){kind=small}
Market Insights Snapshot
In July 2026, Emerald Health Therapeutics operated as a single-category brand with Beverage at 100.0% of sales, pairing a year-over-year decline of 59.6% with a month-over-month drop of 17.4%. Average price moved down 4.6% year over year to $8.06, while brand-level sales contracted 61.2% year over year, indicating that volume fell faster than pricing. With Beverage as the entire mix and no category diversification offsetting the contraction, the pattern implies concentrated exposure where any demand softness or assortment rationalization in Beverage transmits directly into total-brand volatility.
The combination of a 100.0% dependence on Beverage and a 17.4% month-over-month pullback in July 2026 suggests Emerald Health Therapeutics is positioned as a niche Beverage specialist rather than a portfolio balancer, which elevates risk when seasonal or promotional cycles turn. The 59.6% category-level year-over-year decline versus a 61.2% brand-level year-over-year decline, alongside a 4.6% price decrease, implies share defense is constrained by limited price elasticity and SKU breadth; maintaining relevance will likely require either premiumization within Beverage or re-entry into adjacent categories to dilute single-category shock exposure.
Competitive Landscape
Emerald Health Therapeutics sits at rank #32 in ON Beverage in July 2026, down 8 positions year over year from #24 and slipping 3 spots since April 2026 from #29; the brand’s peak was #23 in March 2025, placing today’s position 9 ranks below that high while the category leaders compressed the top five. In contrast, Versus climbed from #3 to #1 while growing sales 18.1% year over year, and Mary Jones advanced from #8 to #5 with a 56.1% sales increase, whereas XMG fell from #1 to #2 alongside a 37.2% sales decline; this divergence suggests Emerald Health Therapeutics is ceding relative shelf velocity to brands with clearer momentum, implying its current trajectory risks further mid-pack drift unless it repositions against the faster-rising leaders.
Notable Products
The steepest decline came from Lime Mint Beverage (10mg THC, 222ml), dropping 46.2% month over month and yet holding rank 1, while Ginger Lime Live Rosin Beverage (10mg THC, 222ml) fell 34.2% and sat at rank 2. With both top positions occupied by Beverage SKUs and each posting double-digit declines, the pattern implies over-reliance on a narrow beverage lineup that is losing velocity faster than rank attrition suggests, signaling a need to diversify formats or refresh formulations to stabilize demand.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
